Recommended shielding against SARS-CoV-2 impacts physical activity levels and adherence to airway clearance therapy in patients with cystic fibrosis
E. Hatziagorou (Thessaloniki, Greece), I. Toulia (Thessaloniki, Greece), P. Peftoulidou (Thessaloniki, Greece), E. Kouroukli (Thessaloniki, Greece), E. Tasika (Thessaloniki, Greece), E. Chrysochoou (Thessaloniki, Greece), J. Tsanakas (Thessaloniki, Greece)
Source: Virtual Congress 2021 – Cystic fibrosis in children: various aspects
Session: Cystic fibrosis in children: various aspects
Session type: E-poster
Number: 3371
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Hatziagorou (Thessaloniki, Greece), I. Toulia (Thessaloniki, Greece), P. Peftoulidou (Thessaloniki, Greece), E. Kouroukli (Thessaloniki, Greece), E. Tasika (Thessaloniki, Greece), E. Chrysochoou (Thessaloniki, Greece), J. Tsanakas (Thessaloniki, Greece). Recommended shielding against SARS-CoV-2 impacts physical activity levels and adherence to airway clearance therapy in patients with cystic fibrosis. 3371
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Variation in lung function as a marker of adherence to oral and inhaled medication in cystic fibrosis Source: Eur Respir J , 49 (3) 1600987; DOI: 10.1183/13993003.00987-2016 Year: 2017
Assessment of Lumacaftor/Ivacaftor therapy on physical activity and exercise tolerance in adults with cystic fibrosis Source: Virtual Congress 2020 – Clinical monitoring and new therapies for cystic fibrosis Year: 2020
Effect of home intravenous antibiotic treatment on exercise capacity in children with cystic fibrosis Source: Annual Congress 2010 - Gas exchange and paediatric exercise testing Year: 2010
Lung function parameters influence serum concentration after antibiotic inhalation in patients with cystic fibrosis Source: Eur Respir J 2001; 18: Suppl. 33, 537s Year: 2001
Relationships between bronchodilator therapy, resting energy expenditure and systemic inflammation in cystic fibrosis Source: Eur Respir J 2003; 22: Suppl. 45, 503s Year: 2003
Short-term effects of physiotherapy on ventilation inhomogeneity in cystic fibrosis patients with moderate to severe lung disease Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children Year: 2013
Factors affecting the compliance to antifibrotic treatment in patients with interstitial pulmonary fibrosis Source: International Congress 2019 – The world of idiopathic pulmonary fibrosis Year: 2019
RhDNase after airway clearance therapy improves peripheral airway patency in children with cystic fibrosis Source: Annual Congress 2006 - Cystic fibrosis lung disease: molecules images and drugs Year: 2006
Comparison of exercise capacity, physical activity level and quality of life in patients with different severity of non-cystic fibrosis bronchiectasis> Source: Virtual Congress 2021 – Peripheral muscle function, exercise capacity and functional status in respiratory disease Year: 2021
Changes in mechanical properties of respiratory system in children with cystic fibrosis during therapy of exacerbation Source: Eur Respir J 2005; 26: Suppl. 49, 612s Year: 2005
Increase motivation and efficiecy in cystic fibrosis teenagers using sport activities, respiratory muscle training and airway clearance techniques Source: Annual Congress 2012 - The latest insights in chronic care Year: 2012
Correlation of physical fitness with peripheral muscle strength, physical activity levels and lung function in patients with cystic fibrosis Source: International Congress 2018 – Cystic fibrosis in adults: current research Year: 2018
Longitudinal relationship between physical activity and lung health in patients with cystic fibrosis Source: Eur Respir J 2014; 43: 817-823 Year: 2014
Feasibility study of an intervention to increase treatment adherence in children with cystic fibrosis (CF) Source: International Congress 2019 – Treatments, adherence and psychosocial aspects of cystic fibrosis Year: 2019
The treatment burden of cystic fibrosis: a day-to-day experience with treatment as someone with cystic fibrosis Source: Breathe, 17 (1) 210013; 10.1183/20734735.0013-2021 Year: 2021
Lack of therapeutic potential for topical metformin in treatment of airway secretion dehydration in cystic fibrosis Source: Annual Congress 2009 - Cystic fibrosis: understanding a complex disease Year: 2009
The effect of Simeox airway clearance technology on resting hyperinflation in Cystic fibrosis patients Source: Virtual Congress 2020 – New insights into respiratory physiotherapy Year: 2020
The cystic fibrosis lung microenvironment alters antibiotic activity: causes and effects Source: Eur Respir Rev, 30 (161) 210055; 10.1183/16000617.0055-2021 Year: 2021
The effect of lung volume reduction on the success of physical activity coaching in patients with severe COPD Source: Virtual Congress 2020 – Physical activity and chronic lung disease: once a new kid, now growing up Year: 2020
Airway clearance techniques, pulmonary rehabilitation and physical activity Source: Eur Respir Monogr 2018; 81: 331-352 Year: 2018